Brief: Alphamab Oncology Says Unit & Institut Pasteur Of Shanghai Entered Into Cooperative Development Agreement
10/06/2020 02:39
June 10 (Reuters) - Alphamab Oncology 9966.HK :
* UNIT & INSTITUT PASTEUR OF SHANGHAI, CHINESE ACADEMY OF
SCIENCES
ENTERED INTO COOPERATIVE DEVELOPMENT AGREEMENT
* AGREEMENT FOR CO-DEVELOPMENT OF ANTIBODY FOR CORONAVIRUS
TREATMENT
Source text for Eikon: urn:newsml:reuters.com:*:nHKS9s7TlD
Further company coverage: 9966.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)